Viewing Study NCT04251533


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-31 @ 9:54 PM
Study NCT ID: NCT04251533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-05
First Post: 2020-01-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
Sponsor: Novartis Pharmaceuticals
Organization: